Statins significantly reduce mortality risk for adults with diabetes, regardless of CV risk,suggests study Dr. Kamal Kant Kohli30 Dec 2025 9:15 PM ISTA large cohort study found that statins significantly reduce the risk of death and major cardiovascular events in adults with type 2 diabetes, even...
SGLT2 Inhibitors Linked to Lower Mortality but Higher Cardiovascular Complications in Patients with Hypertrophic Cardiomyopathy and Type 2 Diabetes: AHJ, December 2025 Dr. Bhumika Maikhuri30 Dec 2025 10:30 AM ISTA recent study found that Sodium-glucose co-transporter 2 (SGLT2) inhibitors use in hypertrophic cardiomyopathy (HCM) patients with type 2 diabetes...
Bariatric Surgery Ensures Superior Long-Term Weight and Glycemic Outcomes: Study Dr Riya Dave29 Dec 2025 8:45 PM ISTResearchers have found in a new study that patients undergoing metabolic bariatric surgery show better weight loss and glycemic control compared to...
Preoperative Glycemic Control May Predict Diabetes Remission After Metabolic Surgery: Study Medha Baranwal27 Dec 2025 9:15 AM ISTBrazil: Researchers have found in a new study that preoperative capillary blood glucose levels show good specificity in predicting remission of type 2...
SGLT-2 Inhibitors Have Neutral Impact on Incidence of Diabetic Retinopathy Risk: Study Finds Medha Baranwal23 Dec 2025 11:15 AM ISTSpain: Researchers have found in a new study that sodium-glucose cotransporter-2 (SGLT-2) inhibitors have a neutral effect on the incidence of...
Natural Light Exposure Improves Blood Glucose Control in Type 2 Diabetes: Study Dr Riya Dave23 Dec 2025 9:30 AM ISTA study published in Cell Metabolism has found that exposure to natural daylight through windows significantly improved glycemic control in people...
Low-dose aspirin linked to lower cardiovascular event risk for adults with Type 2 diabetes: Study Dr. Kamal Kant Kohli22 Dec 2025 8:30 PM ISTPeople with Type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a...
Tirzepatide Matches Dulaglutide for Cardiovascular Protection With Added Metabolic Benefits: NEJM Dr Riya Dave22 Dec 2025 11:00 AM ISTIn a large randomized trial involving patients with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide was...
GLP-1 Receptor Agonists Linked to Lower All-Cause Mortality in Hypertrophic Cardiomyopathy: AHJ, December 2025 Study Reveals New Cardiovascular Benefits Dr. Bhumika Maikhuri19 Dec 2025 10:30 AM ISTA recent study found that Glucagon-like peptide-1 (GLP-1) receptor agonist use in hypertrophic cardiomyopathy (HCM) patients with type 2 diabetes...
Integrating Low-Cost Interventions: Yoga and Walking Demonstrate Significant Glycemic Benefit in Type 2 Diabetes Dr. Bhumika Maikhuri18 Dec 2025 12:15 PM ISTA recent study found a substantial time-dependent decrease in acute blood glucose levels (FBS and PPBS) in patients with type 2 diabetes, with the...
Incretin-Based Drugs Not Tied to Increased Risk of Acute Pancreatitis Among Diabetics: Study Medha Baranwal18 Dec 2025 8:45 AM ISTUSA: Researchers have found in a new study that among patients with type 2 diabetes, incretin-based medications (GLP-1 receptor agonists and DPP-4...
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk: Study Dr. Kamal Kant Kohli17 Dec 2025 9:15 PM ISTA systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists...
